Citadel Advisors’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Sell |
|
|||||
|
2025
Q1 | $250K | Sell |
|
|||||
|
2024
Q4 | $820K | Buy |
|
|||||
|
2024
Q3 | $630K | Buy |
|
|||||
|
2024
Q2 | $172K | Buy |
|
|||||
|
2024
Q1 | $34.8K | Sell |
|
|||||
|
2023
Q4 | $669K | Sell |
|
|||||
|
2023
Q3 | $2.72M | Buy |
|
|||||
|
2023
Q2 | $5.84M | Buy |
|
|||||
|
2023
Q1 | $5.69M | Buy |
|
|||||
|
2022
Q4 | $4.41M | Buy |
|
|||||
|
2022
Q3 | $2.1M | Sell |
|
|||||
|
2022
Q2 | $2.58M | Buy |
|
|||||
|
2022
Q1 | $2.98M | Sell |
|
|||||
|
2021
Q4 | $4.96M | Buy |
|
|||||
|
2021
Q3 | $3.55M | Sell |
|
|||||
|
2021
Q2 | $9.45M | Sell |
|
|||||
|
2021
Q1 | $15.7M | Buy |
|
|||||
|
2020
Q4 | $9.38M | Sell |
|
|||||
|
2020
Q3 | $12.7M | Buy |
|
|||||
|
2020
Q2 | $3.13M | Sell |
|
|||||
|
2020
Q1 | $9.5M | Buy |
|
|||||
|
2019
Q4 | $8.08M | Sell |
|
|||||
|
2019
Q3 | $19.8M | Buy |
|
|||||
|
2019
Q2 | $20.5M | Buy |
|
|||||
|
2019
Q1 | $2.45M | Buy |
|
|||||
|
2018
Q4 | $2.11M | Sell |
|
|||||
|
2018
Q3 | $8.7M | Buy |
|
|||||
|
2018
Q2 | $3.06M | Sell |
|
|||||
|
2018
Q1 | $4.13M | Sell |
|
|||||
|
2017
Q4 | $5.28M | Sell |
|
|||||
|
2017
Q3 | $5.47M | Sell |
|
|||||
|
2017
Q2 | $11.8M | Buy |
|
|||||
|
2017
Q1 | $181K | Sell |
|
|||||
|
2016
Q4 | $365K | Buy |
|
|||||
|
2016
Q3 | $87K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $77K | Buy |
|
|||||
|
2015
Q4 | $11K | Sell |
|
|||||
|
2015
Q3 | $217K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $1M | Sell |
|
|||||
|
2014
Q4 | $2.51M | Buy |
|
|||||
|
2014
Q3 | $1.54M | Sell |
|
|||||
|
2014
Q2 | $2.58M | Buy |
|
|||||
|
2014
Q1 | $1.21M | Sell |
|
|||||
|
2013
Q4 | $981K | Buy |
|
|||||
|
2013
Q3 | $130K | Buy |
|
|||||
|
2013
Q2 | $77K | Buy |
|